title: "In situ" vaccination for systemic effects in follicular lymphoma.
abstract: Therapeutic vaccines for follicular lymphoma have had limited success. A novelin situimmunotherapeutic strategy combining 3 different treatment modalities induced regression of disseminated follicular lymphoma, which correlated with systemic antitumor T-cell immunity. These results should renew interest in the development of local combined radio- and immunotherapies to achieve abscopal effects.
authors.affiliation: Department of Oncology; Oslo University Hospital Radiumhospitalet ; Oslo, Norway ; K.G. Jebsen Center for Cancer Immunotherapy; Institute for Clinical Medicine; University of Oslo ; Oslo, Norway.
authors.forename: Arne
authors.initials: A
authors.lastname: Kolstad
authors.affiliation: Department of Cancer Immunology; Oslo University Hospital Radiumhospitalet ; Oslo, Norway ; K.G. Jebsen Center for Cancer Immunotherapy; Institute for Clinical Medicine; University of Oslo ; Oslo, Norway.
authors.forename: Johanna
authors.initials: J
authors.lastname: Olweus
keywords: abscopal; cancer vaccine; dendritic cells; follicular lymphoma; immunotherapy; radiotherapy; rituximab